Vimarsana
Biggest News Aggregation in the World

Page 12 - Divi Lab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Divi Lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Divi Lab Today - Breaking & Trending Today

Bulls back on Dalal Street: Here are 3 factors that pulled Nifty, Sensex up 1% on September 29 - Vimarsana News

Bulls back on Dalal Street: Here are 3 factors that pulled Nifty, Sensex up 1% on September 29

Nifty and Senex jumped 1 percent on September 29. According to analysts, the ‘triple whammy’ of up-trending dollar, US bond yields and Brent crude is showing signs of easing, and if this continues, it will facilitate a recovery in markets

Pharma stocks surge up to 9.5% on fresh hopes in US; Glenmark leads rally - Vimarsana News

Pharma stocks surge up to 9.5% on fresh hopes in US; Glenmark leads rally

Pharma stocks surged nearly 10% on Friday taking Nifty Pharma index up 3%, with Glenmark Pharma seeing the largest rise of up to 9.5 percent. Here's what's fuelling the rally in Pharma stocks.

Pharma stocks gains up to 10%: What's fuelling the rally - Vimarsana News

Pharma stocks gains up to 10%: What's fuelling the rally

Some pharma companies, on September 29, gained as much as 10%

Meet daughter of richest Indian scientist, who is director of Rs 1 lakh crore firm; her net worth is... - Vimarsana News

Meet daughter of richest Indian scientist, who is director of Rs 1 lakh crore firm; her net worth is...

Nilima Motaparti, one of the wealthiest women in India with a stated net worth of over Rs 28,180 crore as of March 2023, is one such successful person. Murali Krishna Divi, who started Divi's Laboratories, is the father of Nilima Motapatri.

Pharma deep dive: Not the time to buy hospitals, bullish on diagnostics, says Incred's Khemka - Vimarsana News

Pharma deep dive: Not the time to buy hospitals, bullish on diagnostics, says Incred's Khemka

Khemka also says there are many reasons unbranded generics won’t work in India.